Medable, a US-based software provider for decentralised clinical trials, and Datavant, a firm that aids healthcare organisations connect their data, have partnered to help clinical trial teams easily integrate multiple data sources.

With the intergration of several data sources, it becomes possible to speed up decentralised trial design, recruitment, and data management.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Medable will integrate Datavant’s technology into its decentralised trials platform, enabling trial teams to bring together real-world health records, claims, diagnostic and other data sources with clinical trial data.

This integration will remove several manual and time-taking steps, which in turn slow down clinical trials.

Furthermore, it boosts patient access and helps trial teams to optimise evidence generation both during and after studies.

Medable CEO and co-founder Michelle Longmire said: “Making it easier to integrate multiple data sources is an important step in our mission to reduce clinical trial timelines by 50%.

“Datavant provides us with a broad array of built-in connections to real-world data sources, which can now be combined to yield a more holistic view of patient health than clinical trial data alone.”

Datavant’s technology enables linking de-identified data across a patient’s complete journey.

On linking real-world data sources with other sources of study data, the team working on the clinical trial will be able to produce and submit real-world evidence for regulatory analysis.

Datavant CEO Travis May said: “Accelerating the pace of clinical development will help patients get access to life-saving therapies more quickly.

“We’re excited to help power Medable’s work in accelerating clinical trials by making it easier to connect to the ecosystem of real-world data.”

Earlier this year, Medable began working with Datavant as part of a multi-company research framework to speed up the development of diagnostics and treatments for Covid-19.

The ACCESS initiative, which stands for American Covid-19 Collaborative Enabling Seamless Science, offers a mobile application and safe infrastructure to link health researchers and clinical trial teams with individuals in the US.

Last month, US-based life sciences firm LabCorp has announced that Covance, its drug development business, is bolstering its technology ecosystem to speed up the adoption of decentralised clinical trials.

Through an alliance with software provider for digital clinical trials Medable, Covance is expanding its decentralised clinical trials technology ecosystem.